Naturex Inc.
USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Naturex ranks #24,853 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.
- #24,853
- of 49,997 US assignees by volume
- 28th percentile
- by Innovation Score (28.6/100)
- 13.9
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R24853 · US Corporation #24,853 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #24,853/49,997
- PHOTO-FINISH Naiad Maritime Group
- CPC-NARROW A61P · 8 areas
- INNOV-THIN 28.6/100
- CLAIMS-RICH 13.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Naiad Maritime Group, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Naturex’s 28.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Naturex
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- SpineCore · near 29
SpineCore · near
29 score
- Triumph Pharmaceutic… · near 29
Triumph Pharmaceutic… · near
29 score
- Escape Fitness · near 29
Escape Fitness · near
29 score
- Naturex · this assignee 29
Naturex · this assignee
29 score
- Zhuhai Juntian… · near 29
Zhuhai Juntian… · near
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Naturex's Innovation Score is 28.6/100 (28th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Naturex?
Each dot is one of Naturex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Naturex’s own 13.9 claims/patent is at or below the 19.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Naturex's grants concentrate
Naturex Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2015. By volume, Naturex sits between Nymi Inc. and Neptune Trading, Inc..
Naturex's three-year grant acceleration
Naturex Inc. shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Naturex's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nymi
Nymi Inc.
11 patents
- Naiad Maritime Gr…
Naiad Maritime Group, Inc.
11 patents
- Nanoholdings
Nanoholdings, LLC
11 patents
- Nanophase
Nanophase Technologies Corporation
11 patents
- Nayya Health
Nayya Health, Inc.
11 patents
- Neone
Neone, Inc.
11 patents
- Neoz Pty
Neoz Pty Ltd
11 patents
- Neptune Trading
Neptune Trading, Inc.
11 patents
- Naturex ◀
Naturex Inc.
11 patents
What this shows Naturex holds 11 patents at rank #24,879, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Naturex
By rank, the assignees closest to #24,879 in granted patent volume.
- Nymi Inc. #24,875 · 11 patents
- Naiad Maritime Group, Inc. #24,876 · 11 patents
- Nanoholdings, LLC #24,877 · 11 patents
- Nanophase Technologies Corporation #24,878 · 11 patents
- Nayya Health, Inc. #24,880 · 11 patents
- Neone, Inc. #24,881 · 11 patents
- Neoz Pty Ltd #24,882 · 11 patents
- Neptune Trading, Inc. #24,883 · 11 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Naturex's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Naturex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Naturex ranks #1,740 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (29 here).
Naturex's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 28th percentile higher than 28% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2016 | 1 | 9.1% |
| 2018 | 3 | 27.3% |
| 2021 | 4 | 36.4% |
| 2022 | 1 | 9.1% |
| 2025partial year | 1 | 9.1% |
Which technologies does Naturex Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Naturex Inc.'s patent record in context - here's where to go next.
- Naturex Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #24,853 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Naturex Inc. against Nymi Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.